Insmed Incorporated is a biopharmaceutical company focused on developing targeted inhaled therapies for patients suffering from rare lung diseases. The company was founded in 1999 and is based in Bridgewater, New Jersey.
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Security division was awarded a contract from the Qatar Company for Airports Operation and Management ("MATAR") for approximately $59 million to provide hold (or checked) baggage screening systems, trace detection systems, and related services for the Hamad International Airport ("HIA") in Qatar. Under the terms of the award, the Company will supply its high-speed Rapiscan® RTT®110 for baggage screening along with its Itemizer® 4DX desktop trace detection system and has commenced deliveries.
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following virtual investor conferences:
OSI Systems, Inc. (NASDAQ: OSIS) today announced that its Optoelectronics and Manufacturing division has received orders for approximately $6 million to provide electronic sub-assemblies for a leading information security technology provider OEM.
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that final results from the Phase 2 WILLOW study of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE) were published online in the New England Journal of Medicine (NEJM). New data from subgroup analyses of the WILLOW study also were presented today during a late-breaking clinical trials session at the virtual European Respiratory Society (ERS) International Congress 2020. Brensocatib is a novel, first-in-class, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1) being developed by Insmed for the treatment of bronchiectasis and other inflammatory diseases.